Pulmonary Rehabilitation in Patients Before Lung Transplantation (LTx)
NCT ID: NCT00962078
Last Updated: 2019-09-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
71 participants
INTERVENTIONAL
2008-07-31
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of an Acute Exacerbation During Pulmonary Rehabilitation in COPD Patients Awaiting Lung Transplantation
NCT04363723
Effect of Inpatient Pulmonary Rehabilitation on Frailty in Candidates for Lung-Transplantation
NCT03895931
Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis
NCT01772667
Personalised Exercise Training in COPD
NCT03817294
Effects of Blood Flow Restriction Aerobic Exercise on Inflammation, Hypoxia, Exercise Capacity, and Lung Function in COPD
NCT07261293
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
interval training
interval training in lung transplant candidates
interval training
at 100 percent of peak Watt
Continuous Training
continuous training in lung transplant candidates
continuous endurance training
at 60 percent of peak Watt
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
continuous endurance training
at 60 percent of peak Watt
interval training
at 100 percent of peak Watt
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COPD Stadium IV GOLD
* α-1-Antitrypsin-deficiency-Emphysema
* respiratory Insufficiency
* oxygen therapy (LTOT)
Exclusion Criteria
* clinical signs of manifest heart insufficiency
* acute coronar syndrome
* left heart insufficiency(EF \< 40%)
* missing Compliance
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Schön Klinik Berchtesgadener Land
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klaus Kenn
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Klaus Kenn, Dr.med.
Role: STUDY_DIRECTOR
Klinikum Berchtesgadener Land, Schön-Kliniken
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Berchtesgadener Land
Schönau am Königssee, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ethikkommission
Identifier Type: -
Identifier Source: secondary_id
Landesärztekammer Bayern
Identifier Type: -
Identifier Source: secondary_id
Nr. 08022
Identifier Type: -
Identifier Source: secondary_id
PRÄ-LTX-08022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.